Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Service d'aide à la décision clinique
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Annales de Dermatologie et de Vénéréologie
Volume 136, n° S4
pages 86-88 (mai 2009)
Doi : 10.1016/S0151-9638(09)74533-8
Les effets à long terme de la toxine botulique
Long-term effects of botulinum toxin treatment
 

P. Krystkowiak
Service de neurologie, CNRS UMR 8160, CHU d’Amiens, 80054 Amiens cedex 

Résumé

La toxine botulique (BoNT) est utilisée à des fins médicales depuis un quart de siècle. Son excellent profil efficacité/effets indésirables se maintient sur le long terme, comme en attestent toutes les études cliniques concernant diverses indications, la plupart dans le domaine de la neurologie. Qui plus est, les effets indésirables sont, dans la grande majorité des cas, locaux et spontanément réversibles. L’allo-immunisation à la BoNT, par le biais du développement d’anticorps neutralisants, n’entraîne aucune conséquence significative en pratique quotidienne.

The full text of this article is available in PDF format.
Summary

Long-term BoNT treatment administration has been assessed in various treatment settings (especially in neurology), with the level and duration of BoNT efficacy response being maintained with no major safety problems. Most side effects are local one and are transient. The incidence of antibody development is low and does not induce significant concerns in clinical practice.

The full text of this article is available in PDF format.

Mots clés : Traitement à long terme, Toxine botulique, Sérotype A, Anticorps neutralisants

Keywords : Long-term treatment, Botulinum toxin, Serotype A, Neutralizing antibodies




© 2009  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@